Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2

Por um escritor misterioso

Descrição

Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2
Mechanism and inhibition of the papain‐like protease, PLpro, of
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2
Viruses, Free Full-Text
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2
Hit Expansion of a Noncovalent SARS-CoV-2 Main Protease Inhibitor
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2
Repurposing an Antiviral Drug against SARS‐CoV‐2 Main Protease
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2
Discovery of novel non-peptidic and non-covalent small-molecule
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2
Potent and selective covalent inhibition of the papain-like
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2
Inhibition of the main protease of SARS-CoV-2 (Mpro) by
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2
Exploring potential SARS-CoV-2 Mpro non-covalent inhibitors
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2
Beyond the vaccines: a glance at the small molecule and peptide
Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2
Allosteric Binding Sites of the SARS-CoV-2 Main Protease
de por adulto (o preço varia de acordo com o tamanho do grupo)